Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes: The MRI Substudy in AIM-HIGH.

Sun J, Zhao XQ, Balu N, Neradilek MB, Isquith DA, Yamada K, Cantón G, Crouse JR 3rd, Anderson TJ, Huston J 3rd, O'Brien K, Hippe DS, Polissar NL, Yuan C, Hatsukami TS.

JACC Cardiovasc Imaging. 2017 Mar;10(3):241-249. doi: 10.1016/j.jcmg.2016.06.017.

PMID:
28279371
2.

Imaging of the ulcerated carotid atherosclerotic plaque: a review of the literature.

Rafailidis V, Chryssogonidis I, Tegos T, Kouskouras K, Charitanti-Kouridou A.

Insights Imaging. 2017 Apr;8(2):213-225. doi: 10.1007/s13244-017-0543-8. Epub 2017 Feb 3. Review.

3.

Prediction of high-risk plaque development and plaque progression with the carotid atherosclerosis score.

Xu D, Hippe DS, Underhill HR, Oikawa-Wakayama M, Dong L, Yamada K, Yuan C, Hatsukami TS.

JACC Cardiovasc Imaging. 2014 Apr;7(4):366-73. doi: 10.1016/j.jcmg.2013.09.022. Epub 2014 Mar 13.

4.

The carotid plaque imaging in acute stroke (CAPIAS) study: protocol and initial baseline data.

Bayer-Karpinska A, Schwarz F, Wollenweber FA, Poppert H, Boeckh-Behrens T, Becker A, Clevert DA, Nikolaou K, Opherk C, Dichgans M, Saam T.

BMC Neurol. 2013 Dec 13;13:201. doi: 10.1186/1471-2377-13-201.

5.

MRI plaque imaging detects carotid plaques with a high risk for future cerebrovascular events in asymptomatic patients.

Esposito-Bauer L, Saam T, Ghodrati I, Pelisek J, Heider P, Bauer M, Wolf P, Bockelbrink A, Feurer R, Sepp D, Winkler C, Zepper P, Boeckh-Behrens T, Riemenschneider M, Hemmer B, Poppert H.

PLoS One. 2013 Jul 24;8(7):e67927. doi: 10.1371/journal.pone.0067927. Print 2013.

6.

Carotid artery disease and stroke: assessing risk with vessel wall MRI.

Kerwin WS.

ISRN Cardiol. 2012;2012:180710. doi: 10.5402/2012/180710. Epub 2012 Nov 14.

7.

Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study.

Sun J, Underhill HR, Hippe DS, Xue Y, Yuan C, Hatsukami TS.

JACC Cardiovasc Imaging. 2012 Aug;5(8):798-804. doi: 10.1016/j.jcmg.2012.03.014.

8.

Symptomatic and asymptomatic carotid artery plaque.

Mughal MM, Khan MK, DeMarco JK, Majid A, Shamoun F, Abela GS.

Expert Rev Cardiovasc Ther. 2011 Oct;9(10):1315-30. doi: 10.1586/erc.11.120. Review.

9.

MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course.

Zhao XQ, Dong L, Hatsukami T, Phan BA, Chu B, Moore A, Lane T, Neradilek MB, Polissar N, Monick D, Lee C, Underhill H, Yuan C.

JACC Cardiovasc Imaging. 2011 Sep;4(9):977-86. doi: 10.1016/j.jcmg.2011.06.013.

10.

Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies.

Duivenvoorden R, Fayad ZA.

Curr Atheroscler Rep. 2011 Jun;13(3):277-84. doi: 10.1007/s11883-011-0176-1. Review.

11.

MRI plaque imaging and its role in population-based studies.

Yuan C, Berry JD.

BMC Med. 2010 Nov 30;8:78. doi: 10.1186/1741-7015-8-78.

12.
13.

Efficient flow suppressed MRI improves interscan reproducibility of carotid atherosclerosis plaque burden measurements.

Dong L, Wang J, Yarnykh VL, Underhill HR, Neradilek MB, Polissar N, Hatsukami TS, Yuan C.

J Magn Reson Imaging. 2010 Aug;32(2):452-8. doi: 10.1002/jmri.22274.

Supplemental Content

Support Center